Results 21 to 30 of about 26,534 (253)

PHOSPHATE BINDER THERAPY AND SERUM PHOSPHATE CONTROL FOLLOWING INITIATION OF HAEMODIALYSIS

Kidney Research and Clinical Practice, 2012
Hyperphosphataemia is associated with increased all-cause mortality in patients with chronic kidney disease (CKD), but serum phosphate (P) levels can be managed by dialysis, diet and the use of P binders. Serum P data were obtained retrospectively from a
Kimberly Farrand, J Brian Copley, Jamie Heise, Moshe Fridman, Michael Keith, Arthur Silverberg   +5 more
doaj   +1 more source

Comparison of sevelamer and calcium carbonate in prevention of hypomagnesemia in hemodialysis patients

International Journal of Preventive Medicine, 2021
Background: Chronic kidney disease (CKD) is a life-threatening disease with numerous complications. Hemodialysis (HD) patients are prone to magnesium deficiency due to malnutrition, which can cause cardiovascular complications and increase mortality. The
Elahe Jandaghi, Maliheh Yarmohammadi, Raheb Ghorbani, Tahereh Jalali, Ali Khadjeh Salehani, Peiman Mohammad Khani   +5 more
doaj   +1 more source

FERRIC CITRATE: AN IRON-BASED ORAL PHOSPHATE BINDER

Kidney Research and Clinical Practice, 2012
Patients with end-stage renal disease (ESRD) often experience secondary bone and mineral disorder requiring treatment with phosphate-binder (PB) medications, vitamin D sterols, and calcimimetics.
T. Christopher Bond, Rich Mutell, Stephen Wang, Enrique Poradosu, Robert Niecestro Tracy   +4 more
doaj   +1 more source

Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease

Microorganisms, 2020
Gut dysbiosis in patients with chronic kidney disease (CKD) may induce chronic inflammation and increase morbidity. Phosphate-binding agents, generally used in patients with CKD, may potentially change the composition of the gut microbiota.
Ping-Hsun Wu, Po-Yu Liu, Yi-Wen Chiu, Wei-Chun Hung, Yi-Ting Lin, Ting-Yun Lin, Szu-Chun Hung, Rachel Ann Delicano, Mei-Chuan Kuo, Chun-Ying Wu   +9 more
doaj   +1 more source

Sevelamer Carbonate Crystal-Induced Colitis

Case Reports in Gastrointestinal Medicine, 2020
Hyperphosphatemia is a common and well-described complication of end-stage renal disease. Despite strict dietary constraints and compliance, phosphate binders such as calcium acetate and/or sevelamer carbonate are also needed to treat secondary ...
T. Lai, A. Frugoli, B. Barrows, M. Salehpour   +3 more
doaj   +1 more source

Scientific and Experimental Substantiation for the Production of Fireproof and Heat-Resistant Materials from Magnesia-Silicate Rocks

Journal of Architectural and Engineering Research, 2022
Համառոտագիր Հոդվածը նվիրված է տեղական հումքով՝ Սևանի մագնեզիումասիլիկատային ապարներով, հրակայուն և կրակակայուն բետոնների ստացման տեխնոլոգիաների մշակմանը, որոնք կարող են օգտագործվել ջերմային ագրեգատներում՝ փոխարինելով շարվածքի մանրահատ աղյուսներին ու
Amalya Karapetyan, Maria Badalyan
doaj   +1 more source

Enteral Ca-Intake May Be Low and Affects Serum-PTH-Levels in Pre-school Children With Chronic Kidney Disease

Frontiers in Pediatrics, 2021
Treatment of chronic kidney disease (CKD) mineral bone disorder (MBD) is challenging in growing children due to the high amount of calcium needed for normal bone mineralization and the required dietary phosphate restriction, which often includes intake ...
Lilith Schmitz, Pamela Hoermann, Birgit Trutnau, Augustina Jankauskiene, Ariane Zaloszyc, Alberto Carlo Edefonti, Claus Peter Schmitt, Guenter Klaus, Guenter Klaus   +8 more
doaj   +1 more source

Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial

Kidney International Reports, 2020
Introduction: Calciprotein particles (CPPs) are potentially modifiable mediators of phosphate toxicity in patients with kidney disease. We compared the effects of calcium carbonate (CC) and the non–calcium-based phosphate binder sevelamer on CPP levels ...
Edward R. Smith, Fei Fei M. Pan, Tim D. Hewitson, Nigel D. Toussaint, Stephen G. Holt   +4 more
doaj   +1 more source

Pharmacological interactions of phosphate binders

Nefrología (English Edition), 2018
The use of phosphate binders is one of basic elements in the treatment of CKD-MBD (“Chronic Kidney Disease-Mineral and Bone Disorder”). It has been well known for decades that phosphate reten tion through direct and indirect mechanisms, contributes to the generation and progression of secondary hyperparathy roidism (SHP) and renal osteodystrophy in ...
Bover Sanjuan, Jordi, Navarro-Gonzalez, Juan Francisco, Arenas, M Dolores, Torregrosa, Jose-Vicente, Tamargo Menendez, Juan, de Francisco, Angel Luis Martin, Gonzalez-Parra, Emilio, Lloret Cora, M Jesus, Sanchez Alvarez, J Emilio, Martin-Malo, Alejandro, Molina Vila, Pablo, Bajo, M Auxiliadora, DaSilva Santos, Iara   +12 more
openaire   +4 more sources

Granulated organomineral fertilizers from by-products of the agricultural and forestry sector [PDF]

Scientia Agricola
The present study evaluated the granular properties of organomineral fertilizers produced from charcoal fines (biochar) and natural phosphate with three distinct binders: cassava wastewater (CW), pyroligneous extract (PE), and bio-oil (BO). The objective
José Mendes dos Santos Júnior, Fernando Colen, Leidivan Almeida Frazão, Rodinei Facco Pegoraro, Luiz Arnaldo Fernandes   +4 more
doaj   +1 more source